Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor-associated sorting protein 2 (GPRASP2) is a protein that regulates the internalization, trafficking, and degradation of a variety of G protein-coupled receptors (GPCRs), including muscarinic acetylcholine receptors and calcitonin receptors. As a member of the GPRASP family, GPRASP2 influences GPCR activity by directing receptors to lysosomal degradation pathways, thus affecting receptor signaling duration and synaptic plasticity. Loss of GPRASP2 function has been associated with altered synaptic development, memory, social behaviors, and neurodevelopmental disorders such as autism spectrum disorder and X-linked deafness. There is no evidence for its direct use as a therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor-associated sorting protein 2 (GPRASP2).